159 related articles for article (PubMed ID: 10889823)
1. Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate.
Van Leenders GJ; Beerlage HP; Ruijter ET; de la Rosette JJ; van de Kaa CA
J Clin Pathol; 2000 May; 53(5):391-4. PubMed ID: 10889823
[TBL] [Abstract][Full Text] [Related]
2. Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy.
Dalfior D; Delahunt B; Brunelli M; Parisi A; Ficarra V; Novara G; Novella G; Gobbo S; Valotto C; Chilosi M; Menestrina F; Martignoni G
Pathology; 2010 Jan; 42(1):1-5. PubMed ID: 20025473
[TBL] [Abstract][Full Text] [Related]
3. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma.
Beerlage HP; Thüroff S; Debruyne FM; Chaussy C; de la Rosette JJ
Urology; 1999 Aug; 54(2):273-7. PubMed ID: 10443724
[TBL] [Abstract][Full Text] [Related]
4. High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study.
Beerlage HP; van Leenders GJ; Oosterhof GO; Witjes JA; Ruijter ET; van de Kaa CA; Debruyne FM; de la Rosette JJ
Prostate; 1999 Apr; 39(1):41-6. PubMed ID: 10221265
[TBL] [Abstract][Full Text] [Related]
5. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer.
Sedelaar JP; Aarnink RG; van Leenders GJ; Beerlage HP; Debruyne FM; Wijkstra H; de La Rosette JJ
Eur Urol; 2000 May; 37(5):559-68. PubMed ID: 10765094
[TBL] [Abstract][Full Text] [Related]
6. Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU).
Biermann K; Montironi R; Lopez-Beltran A; Zhang S; Cheng L
Prostate; 2010 Aug; 70(11):1196-200. PubMed ID: 20564422
[TBL] [Abstract][Full Text] [Related]
7. Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue.
Ryan P; Finelli A; Lawrentschuk N; Fleshner N; Sweet J; Cheung C; van der Kwast T; Evans A
J Clin Pathol; 2012 Aug; 65(8):729-34. PubMed ID: 22659332
[TBL] [Abstract][Full Text] [Related]
8. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
Chen YB; Fine SW; Epstein JI
Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
[TBL] [Abstract][Full Text] [Related]
9. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
10. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
[TBL] [Abstract][Full Text] [Related]
11. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
[TBL] [Abstract][Full Text] [Related]
12. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
[TBL] [Abstract][Full Text] [Related]
13. Effect of high-intensity focused ultrasound on human prostate cancer in vivo.
Madersbacher S; Pedevilla M; Vingers L; Susani M; Marberger M
Cancer Res; 1995 Aug; 55(15):3346-51. PubMed ID: 7542168
[TBL] [Abstract][Full Text] [Related]
14. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
15. Utility of immunohistochemistry markers in the interpretation of post-high-intensive focussed ultrasound prostate biopsy cores.
Walter B; Weiss T; Hofstädter F; Gaumann A; Hartmann A; Rogenhofer S; Ganzer R; Wach S; Engehausen D; Wieland WF; Blana A
World J Urol; 2013 Oct; 31(5):1129-33. PubMed ID: 22350516
[TBL] [Abstract][Full Text] [Related]
16. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
[TBL] [Abstract][Full Text] [Related]
17. High-intensity focused ultrasound for prostate cancer: a systematic review.
Lukka H; Waldron T; Chin J; Mayhew L; Warde P; Winquist E; Rodrigues G; Shayegan B;
Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):117-27. PubMed ID: 20932728
[TBL] [Abstract][Full Text] [Related]
18. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
19. Visualisation of HIFU lesions using elastography of the human prostate in vivo: preliminary results.
Souchon R; Rouvière O; Gelet A; Detti V; Srinivasan S; Ophir J; Chapelon JY
Ultrasound Med Biol; 2003 Jul; 29(7):1007-15. PubMed ID: 12878247
[TBL] [Abstract][Full Text] [Related]
20. High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer: A Review.
Chaussy CG; Thüroff S
J Endourol; 2017 Apr; 31(S1):S30-S37. PubMed ID: 28355119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
